GeneDx Holdings Corp. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.68 | -$0.64 | -$0.67 |
| Q2 2024 | 1 | -$0.31 | -$0.29 | -$0.30 |
| Q3 2024 | 1 | -$0.22 | -$0.21 | -$0.22 |
| Q4 2024 | 2 | $0.10 | $0.11 | $0.11 |
| Q1 2025 | 2 | $0.06 | $0.06 | $0.06 |
| Q2 2025 | 1 | $0.09 | $0.09 | $0.09 |
| Q3 2025 | 1 | $0.14 | $0.15 | $0.14 |
| Q4 2025 | 1 | $0.16 | $0.17 | $0.17 |
| Q1 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q3 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q4 2026 | 0 | $0.00 | $0.00 | $0.00 |
GeneDx Holdings Corp. Earnings Date And Information
GeneDx Holdings Corp. last posted its earnings results on Tuesday, October 29th, 2024. The company reported $0.04 earnings per share for the quarter, topping analysts' consensus estimates of $-0.19 by $0.23. The company had revenue of 76.87 M for the quarter and had revenue of 202.57 M for the year. GeneDx Holdings Corp. has generated $-7 earnings per share over the last year ($-7.23 diluted earnings per share) and currently has a price-to-earnings ratio of -25.62. GeneDx Holdings Corp. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 18th, 2025 based on prior year's report dates.
GeneDx Holdings Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/29/2024 | Q3 2024 | -$0.19 | -$0.31 | -0.12 | $64.98 M | $76.87 M |
| 07/30/2024 | Q2 2024 | -$0.26 | -$1.10 | -0.84 | $59.31 M | $70.51 M |
| 03/29/2024 | Q1 2024 | -$0.78 | $62.42 M | |||
| 12/29/2023 | Q4 2023 | -$0.99 | $57.42 M | |||
| 09/30/2023 | Q3 2023 | -$1.64 | $52.42 M | $53.30 M | ||
| 06/30/2023 | Q2 2023 | -$1.84 | $47.59 M | $48.71 M | ||
| 03/31/2023 | Q1 2023 | -$3.04 | $43.14 M | |||
| 12/31/2022 | Q4 2022 | -$26.23 | $61.35 M | |||
| 11/14/2022 | Q3 2022 | -$0.21 | -$0.20 | 0.01 | $67.74 M | $83.23 M |
| 08/15/2022 | Q2 2022 | -$0.21 | -$0.25 | -0.04 | $67.55 M | $36.17 M |
| 05/12/2022 | Q1 2022 | -$0.31 | -$0.26 | 0.05 | $53.94 M | |
| 03/14/2022 | Q4 2021 | -$0.26 | -$0.17 | 0.09 | $57.80 M | |
| 11/15/2021 | Q3 2021 | -$0.19 | $5.94 | 6.13 | $42.67 M | $43.18 M |
| 07/21/2021 | Q2 2021 | -$6.23 | $46.87 M | |||
| 03/30/2021 | Q1 2021 | -$26.35 | $64.20 M | |||
| 12/30/2020 | Q4 2020 | -$0.52 | $63.96 M | |||
| 09/29/2020 | Q3 2020 | -$7.78 | $38.61 M |
GeneDx Holdings Corp. Earnings: Frequently Asked Questions
-
When is GeneDx Holdings Corp.'s earnings date?
GeneDx Holdings Corp. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 18th, 2025 based off last year's report dates.
-
Did GeneDx Holdings Corp. beat their earnings estimates last quarter?
In the previous quarter, GeneDx Holdings Corp. (:WGS) reported $0.04 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.19 by $0.23.
-
How can I listen to GeneDx Holdings Corp.'s earnings conference call?
The conference call for GeneDx Holdings Corp.'s latest earnings report can be listened to online.
-
How can I read GeneDx Holdings Corp.'s conference call transcript?
The conference call transcript for GeneDx Holdings Corp.'s latest earnings report can be read online.
-
How much revenue does GeneDx Holdings Corp. generate each year?
GeneDx Holdings Corp. (:WGS) has a recorded annual revenue of $202.57 M.
-
How much profit does GeneDx Holdings Corp. generate each year?
GeneDx Holdings Corp. (:WGS) has a recorded net income of $202.57 M. GeneDx Holdings Corp. has generated $-7.23 earnings per share over the last four quarters.
-
What is GeneDx Holdings Corp.'s price-to-earnings ratio?
GeneDx Holdings Corp. (:WGS) has a price-to-earnings ratio of -25.62 and price/earnings-to-growth ratio is -0.87.
